Compounds > paroxetine
Page last updated: 2024-08-23

paroxetine and Local Neoplasm Recurrence

paroxetine has been researched along with Local Neoplasm Recurrence in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boudreau, DM; Bowles, EJ; Buist, DS; Chubak, J; Fujii, M; Yu, O1
Ahmed, SA; Avila, C; Cheetham, TC; Chung, J; Fletcher, SW; Habel, LA; Haque, R; Kleinman, K; Kwan, ML; Schottinger, JE; Shi, J1
Baker, H1

Other Studies

3 other study(ies) available for paroxetine and Local Neoplasm Recurrence

ArticleYear
Breast cancer recurrence in relation to antidepressant use.
    Cancer causes & control : CCC, 2016, Volume: 27, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Breast Neoplasms; Depressive Disorder; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Paroxetine; Risk; Young Adult

2016
Tamoxifen and Antidepressant Drug Interaction in a Cohort of 16,887 Breast Cancer Survivors.
    Journal of the National Cancer Institute, 2016, Volume: 108, Issue:3

    Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cohort Studies; Depression; Female; Health Resources; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Odds Ratio; Paroxetine; Proportional Hazards Models; Survivors; Tamoxifen; United States

2016
Use of antidepressants and breast cancer recurrence.
    The Lancet. Oncology, 2016, Volume: 17, Issue:1

    Topics: Antidepressive Agents, Second-Generation; Antineoplastic Agents, Hormonal; Breast Neoplasms; Depression; Female; Humans; Neoplasm Recurrence, Local; Paroxetine; Tamoxifen

2016